Latest News about Merck & Co Inc
Recent news which mentions Merck & Co Inc
From CNBC.com News
Merck CEO talks medicines beyond the company's top cancer drug
January 14, 2025
From CNBC.com News
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
December 18, 2024
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
November 14, 2024
From CNBC.com News
Jim Cramer names hot sectors that could use a pullback
November 14, 2024
From CNBC.com News
Cramer's Lighting Round: S&P Global is a buy
November 05, 2024
From CNBC.com News
From CNBC.com News
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
October 31, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
From CNBC.com News
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
From CNBC.com News
Cramer's Lightning Round: 'I like Target right here'
October 08, 2024
From CNBC.com News
Tuesday's big stock stories: What’s likely to move the market in the next trading session
September 09, 2024
From CNBC.com News
88 corporate leaders endorse Harris in new letter, including CEOs of Yelp, Box and Ripple
September 06, 2024
From CNBC.com News
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
From CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
August 14, 2024
From CNBC.com News
Cramer's Lightning Round: Merck is a buy
August 08, 2024
From CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
From CNBC.com News
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
July 30, 2024
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
From CNBC.com News
From CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.